Chemical Component Summary

Name(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
FormulaC23 H19 N3 O2
Molecular Weight369.42
TypeNON-POLYMER
Isomeric SMILESc1ccc2c(c1)c(c[nH]2)[C@H]3[C@@H](C(=O)NC3=O)c4cn5c6c4cccc6CCC5
InChIInChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1
InChIKeyUCEQXRCJXIVODC-PMACEKPBSA-N

Chemical Details

Formal Charge0
Atom Count47
Chiral Atom Count2
Bond Count52
Aromatic Bond Count20

Drug Info: DrugBank

DrugBank IDDB12200 
NameTivantinib
Groupsinvestigational
DescriptionTivantinib has been investigated in Solid Tumors.
SynonymsTivantinib
Categories
  • Heterocyclic Compounds, Fused-Ring
  • Proto-Oncogene Proteins c-met, antagonists & inhibitors
  • Pyrrolidines
CAS number905854-02-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Hepatocyte growth factor receptorMKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAET...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem11494412
ChEBICHEBI:91398
ChEMBLCHEMBL2103882